DarioHealth wins New Jersey health plan contract covering 1.5M lives
DarioHealth has signed a contract with a New Jersey healthcare plan covering 1.5 million subscribers.
Considered entry after confirming the positive news of securing a large subscriber base through the New Jersey healthcare plan contract. However, a cautious approach is required given the candlestick trend at the time of entry (such as the recent 7-day volatility of -6.4%).
Based on the positive news of the contract signing and the candlestick pattern, we will take profits if the stock price rises to reach the take-profit target of $8.06, and cut losses if downward pressure increases and it breaks below the stop-loss price of $6.45.
RSI (14) is at 46.5, showing neutral momentum, and moving averages are not in a bullish alignment. Trading volume is relatively low at 0.32 times the 20-day average, and the volatility over the past 7 days recorded -6.4%.
Despite the positive catalyst of signing a contract with a New Jersey healthcare plan, the actual result fell short of the projected 2.5% return, recording an actual return of -14.5%, breaching the stop-loss price of $6.45, and receiving a FAILED rating. At the time of entry, there were technical and supply-demand warning signs indicating downward pressure and weakening momentum, such as an RSI(14) of 46.5, a non-bullish moving average alignment, sluggish trading volume amounting to just 0.32 times the 20-day average, a -6.4% volatility rate over the past 7 days, and a falling thematic news trend. It is regrettable that excessive weight was placed solely on the positive news itself despite these indicators.
Drawing lessons from the failure of this trade, when entering positions in the future, we will take a more conservative approach and apply strict risk management when negative technical and supply-demand indicators—such as irregular moving average alignment, low trading volume, and a declining trend in thematic news—appear simultaneously, alongside the impact of individual favorable news.